A Population Pharmacokinetic Analysis of Nelfinavir Mesylate in Human Immunodeficiency Virus-Infected Patients Enrolled in a Phase III Clinical Trial

A population pharmacokinetic analysis was conducted on nelfinavir in patients infected with human immunodeficiency virus (HIV) who were enrolled in a phase III clinical trial. The data consisted of 509 plasma concentrations from 174 patients who received nelfinavir at a dose of 500 or 750 mg three t...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Antimicrob Agents Chemother
المؤلفون الرئيسيون:	Jackson, Kimberley A., Rosenbaum, Sara E., Kerr, Bradley M., Pithavala, Yazdi K., Yuen, Geoffrey, Dudley, Michael N.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 2000
الموضوعات:	Pharmacology
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89969/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10858338/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.7.1832-1837.2000
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!